Dehydrozingerone protects temozolomide-induced cognitive impairment in normal and C6 glioma rats besides enhancing its anticancer potential

Considering the cognitive impairment induced by temozolomide (TMZ) in glioblastoma survivors, the present study was aimed to evaluate the protective effect of dehydrozingerone (DHZ) against TMZ-induced cognitive impairment (chemobrain) and C6 cell line-induced glioma in male Wistar rats. In both che...

Descripción completa

Detalles Bibliográficos
Autores principales: Pathak, Nandini, Cheruku, Sri Pragnya, Rao, Vanishree, Vibhavari, R. J. A., Sumalatha, Suhani, Gourishetti, Karthik, Rao, C. Mallikarjuna, Kumar, Nitesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498526/
https://www.ncbi.nlm.nih.gov/pubmed/32995109
http://dx.doi.org/10.1007/s13205-020-02427-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498526/
https://www.ncbi.nlm.nih.gov/pubmed/32995109
http://dx.doi.org/10.1007/s13205-020-02427-7

Ejemplares similares